Brief: Lineage Cell Therapeutics Reports First Quarter Results
May 7 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS REPORTS FIRST QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q1 REVENUE $500,000 VERSUS $900,000
* Q1 REVENUE ESTIMATE $711,000 -- REFINITIV IBES DATA
* ANTICIPATE OUR NET OPERATIONAL SPEND FOR 2020 WILL
INCREASE
MODESTLY
* QTRLY LOSS PER SHARE $0.06
Source text for Eikon: ID:nBwdnmlMa
Further company coverage: LCTX.A
((Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million